First Heartland Consultants’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.81M | Buy |
4,010
+245
| +7% | +$250K | 0.31% | 79 |
|
|
2026
Q1 | $3.46M | Buy |
3,765
+34
| +0.9% | +$34.5K | 0.27% | 86 |
|
|
2025
Q4 | $4.01M | Buy |
3,731
+27
| +0.7% | +$25.8K | 0.3% | 78 |
|
|
2025
Q3 | $2.83M | Sell |
3,704
-110
| -3% | -$81.9K | 0.23% | 93 |
|
|
2025
Q2 | $2.97M | Buy |
3,814
+31
| +0.8% | +$24.1K | 0.26% | 83 |
|
|
2025
Q1 | $3.12M | Sell |
3,783
-48
| -1% | -$39.9K | 0.32% | 78 |
|
|
2024
Q4 | $2.96M | Sell |
3,831
-100
| -3% | -$82.8K | 0.3% | 72 |
|
|
2024
Q3 | $3.48M | Sell |
3,931
-234
| -6% | -$210K | 0.37% | 56 |
|
|
2024
Q2 | $3.77K | Sell |
4,165
-29
| -0.7% | -$23.2K | 0.26% | 70 |
|
|
2024
Q1 | $3.26M | Buy |
4,194
+177
| +4% | +$126K | 0.34% | 73 |
|
|
2023
Q4 | $2.34M | Buy |
4,017
+67
| +2% | +$39.1K | 0.28% | 82 |
|
|
2023
Q3 | $2.12M | Buy |
3,950
+59
| +2% | +$30.4K | 0.27% | 88 |
|
|
2023
Q2 | $1.82M | Buy |
3,891
+74
| +2% | +$31K | 0.24% | 96 |
|
|
2023
Q1 | $1.31M | Sell |
3,817
-63
| -2% | -$21.2K | 0.2% | 112 |
|
|
2022
Q4 | $1.42M | Buy |
3,880
+157
| +4% | +$55.7K | 0.23% | 103 |
|
|
2022
Q3 | $1.2K | Sell |
3,723
-292
| -7% | -$92.5K | 0.1% | 112 |
|
|
2022
Q2 | $1.3M | Sell |
4,015
-50
| -1% | -$15K | 0.2% | 100 |
|
|
2022
Q1 | $1.16M | Sell |
4,065
-207
| -5% | -$53.3K | 0.18% | 100 |
|
|
2021
Q4 | $1.18K | Sell |
4,272
-43
| -1% | -$10.9K | 0.05% | 102 |
|
|
2021
Q3 | $997K | Sell |
4,315
-522
| -11% | -$129K | 0.15% | 133 |
|
|
2021
Q2 | $1.11M | Buy |
4,837
+41
| +0.9% | +$8.24K | 0.17% | 128 |
|
|
2021
Q1 | $896K | Sell |
4,796
-546
| -10% | -$107K | 0.14% | 138 |
|
|
2020
Q4 | $902K | Buy |
5,342
+131
| +3% | +$19.6K | 0.15% | 110 |
|
|
2020
Q3 | $771K | Sell |
5,211
-311
| -6% | -$48.1K | 0.15% | 105 |
|
|
2020
Q2 | $907K | Buy |
5,522
+151
| +3% | +$23.2K | 0.18% | 107 |
|
|
2020
Q1 | $745K | Sell |
5,371
-529
| -9% | -$72.7K | 0.19% | 104 |
|
|
2019
Q4 | $775K | Sell |
5,900
-79
| -1% | -$9.16K | 0.15% | 136 |
|
|
2019
Q3 | $669K | Sell |
5,979
-191
| -3% | -$21.3K | 0.14% | 135 |
|
|
2019
Q2 | $684K | Buy |
6,170
+474
| +8% | +$55.8K | 0.16% | 121 |
|
|
2019
Q1 | $739K | Buy |
5,696
+2,124
| +59% | +$258K | 0.21% | 115 |
|
|
2018
Q4 | $413K | Sell |
3,572
-1,323
| -27% | -$148K | 0.15% | 132 |
|
|
2018
Q3 | $525K | Sell |
4,895
-191
| -4% | -$19.1K | 0.16% | 129 |
|
|
2018
Q2 | $434K | Sell |
5,086
-247
| -5% | -$20.3K | 0.15% | 148 |
|
|
2018
Q1 | $413K | Sell |
5,333
-267
| -5% | -$21.5K | 0.12% | 176 |
|
|
2017
Q4 | $473K | Sell |
5,600
-778
| -12% | -$66.2K | 0.14% | 158 |
|
|
2017
Q3 | $546K | Sell |
6,378
-39
| -0.6% | -$3.2K | 0.13% | 203 |
|
|
2017
Q2 | $528K | Buy |
6,417
+155
| +2% | +$12.6K | 0.14% | 193 |
|
|
2017
Q1 | $527K | Sell |
6,262
-140
| -2% | -$11.2K | 0.15% | 188 |
|
|
2016
Q4 | $471K | Sell |
6,402
-167
| -3% | -$12.4K | 0.14% | 182 |
|
|
2016
Q3 | $527K | Sell |
6,569
-189
| -3% | -$15.1K | 0.15% | 166 |
|
|
2016
Q2 | $532 | Sell |
6,758
-11
| -0.2% | -$828 | 0.06% | 150 |
|
|
2016
Q1 | $487K | Buy |
6,769
+37
| +0.5% | +$2.8K | 0.19% | 142 |
|
|
2015
Q4 | $567K | Sell |
6,732
-10
| -0.1% | -$830 | 0.22% | 123 |
|
|
2015
Q3 | $564K | Buy |
6,742
+72
| +1% | +$6.08K | 0.24% | 119 |
|
|
2015
Q2 | $557 | Buy |
6,670
+191
| +3% | +$14.6K | 0.15% | 128 |
|
|
2015
Q1 | $471K | Sell |
6,479
-49
| -0.8% | -$3.49K | 0.18% | 142 |
|
|
2014
Q4 | $450K | Buy |
6,528
+74
| +1% | +$5K | 0.19% | 149 |
|
|
2014
Q3 | $419K | Buy |
6,454
+14
| +0.2% | +$886 | 0.18% | 153 |
|
|
2014
Q2 | $400K | Buy |
6,440
+302
| +5% | +$18K | 0.18% | 142 |
|
|
2014
Q1 | $361K | Sell |
6,138
-133
| -2% | -$7.42K | 0.18% | 141 |
|
|
2013
Q4 | $320K | Sell |
6,271
-1,252
| -17% | -$62.7K | 0.18% | 135 |
|
|
2013
Q3 | $381K | Sell |
7,523
-3,414
| -31% | -$179K | 0.23% | 131 |
|
|
2013
Q2 | $537K | Buy |
+10,937
| New | +$595K | 0.31% | 87 |
|
Other funds holding LLY
SC
ONB
GIM
First Heartland Consultants's LLY Position: Q2 2026 in Review
First Heartland Consultants increased its Eli Lilly (LLY) stake by 6.5% in Q2 2026, buying an estimated $250K and bringing the position to 4,010 shares worth $4.81M. The position accounts for 0.31% of the portfolio, ranked #79.
First Heartland Consultants first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- First Heartland Consultants held 4,010 shares of Eli Lilly worth $4.81M as of Q2 2026.
- First Heartland Consultants bought 245 Eli Lilly shares in Q2 2026, an estimated $250K.
- Eli Lilly made up 0.31% of First Heartland Consultants's portfolio in Q2 2026, its #79 holding.
- First Heartland Consultants first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.